← Back to All Filings

UNH Exec Receives Dividend Equivalents on Existing RSUs

Low SignificanceDecember 18, 2025 at 5:36:48 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UNH Exec Receives Dividend Equivalents on Existing RSUs

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low

Insider: Zaetta Christopher R Title: EVP & Chief Legal Officer | Relationship: Officer

Transaction: • Type: Grant • Shares: 44.528 • Price: $0.00 • Value: $0 • Owned After: 10,327.804

Key Insight: This is a routine, non-cash acquisition of dividend equivalents on previously granted restricted stock units (RSUs). It has no market impact.

Market Context: The transaction represents a negligible fraction (<0.00001%) of the company's total shares outstanding.

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer received a minor, non-cash grant of 44.528 shares as dividend equivalents on existing restricted stock units (RSUs).
  • Market Impact: Neutral. This transaction is a routine part of executive compensation and has no material impact on the market or share value.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHOSPITAL & MEDICAL SERVICE PLANS

Insider Information

FieldValue
NameZaetta Christopher R
CIK0002025275
Title/PositionEVP & Chief Legal Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved44.528
Price Per Share$0.00
Total Value$0
Shares Owned After10,327.804
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00000%
Shares Transacted44.528
% of Shares Outstanding0.000005%
Post-Transaction Ownership10,327.804 shares (0.00114% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $291.55 billion, this $0 value transaction is financially immaterial.
  • Ownership Concentration: The insider's total holding of 10,327.804 shares represents a negligible fraction (0.00114%) of the total shares outstanding, indicating very low ownership concentration.
  • Dilution Impact: The issuance of 44.528 shares has a virtually zero dilution impact on existing shareholders, representing less than 0.00001% of shares outstanding.
  • Transaction Significance: The transaction is classified as low significance due to its zero monetary value and its minuscule size relative to both the company's market cap and shares outstanding.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a routine, non-discretionary acquisition of dividend equivalents on RSUs as part of a compensation plan. It does not signal any new insider sentiment or information.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open-market transaction and will not affect trading volume.
  • Sentiment Indicator: Neutral. The filing is purely administrative and carries no bullish or bearish signals.

Additional Context

Transaction Notes

  • Special Circumstances: As per footnote 1, the shares represent dividend equivalents paid on outstanding restricted stock units. These are subject to the same vesting terms as the underlying RSUs.
Topics:#SECFiling#Form4#UNH#UnitedHealth#InsiderTrading#ExecutiveComp#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.